In this context, it has to be highlighted that due to their repressive activity on HIF-1 or NF-kB, HIV-protease inhibitors downregulate the expression of VEGF, the most potent inducer of tumor angiogenesis [175,176,177,193]. The gene discussed is NFKB1; the disease is neoplasm.